CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...

The funds will facilitate the clinical progression of ABO-101, the company’s lead therapeutic candidate targeting PH1.

Tel Aviv University scientists say that they can inject CRISPR genetic 'molecular scissors' to shrink tumors by 90%; ...

As other gene editing programs fold or get sold, Arbor Biotechnologies has secured $73.9 million to advance its lead ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Prime Medicine and Beam Therapeutics had common origins in gene editing. Now they're both pursuing treatments for the same ...

The gene therapy world is in turmoil, but Arbor, armed with more than a billion dollars in partnerships and raises, is going forward.

The round will fund a “one-and-done” treatment for a rare kidney condition that its CEO says can address concerns patients ...

Prof. Dan Peer & research team. Researchers from Tel Aviv University utilized CRISPR to cut a single gene from cancer cells ...